Literature DB >> 23456829

Regadenoson and exercise myocardial perfusion imaging: the courtship continues.

Harkawal S Hundal, Gregory S Thomas.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23456829     DOI： 10.1007/s12350-013-9695-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  13 in total

1.  ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).

Authors:  Raymond J Gibbons; Gary J Balady; J Timothy Bricker; Bernard R Chaitman; Gerald F Fletcher; Victor F Froelicher; Daniel B Mark; Ben D McCallister; Aryan N Mooss; Michael G O'Reilly; William L Winters; Raymond J Gibbons; Elliott M Antman; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Richard O Russell; Sidney C Smith
Journal:  J Am Coll Cardiol       Date:  2002-10-16       Impact factor: 24.094

2.  Comparison of hemodynamic and stress testing variables in patients undergoing regadenoson stress myocardial perfusion imaging to regadenoson with adjunctive low-level exercise myocardial perfusion imaging.

Authors:  Rafael Cabrera; Zehra Husain; Gurunanthan Palani; Aarthee S Karthikeyan; Zain Choudhry; Sunita Dhanalakota; Ed Peterson; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2013-02-21       Impact factor: 5.952

3.  A strategy of symptom-limited exercise with regadenoson-as-needed for stress myocardial perfusion imaging: a randomized controlled trial.

Authors:  Matthew W Parker; Donna Chelle Morales; Hanna B Slim; Alan W Ahlberg; Deborah M Katten; Giselle Cyr; Shishir Mathur; Afrooz Ardestani; Dimitrios Barmpouletos; Geeta Swamy Iyah; Steven M Borer; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2012-11-28       Impact factor: 5.952

4.  Regadenoson pharmacologic stress for myocardial perfusion imaging: a three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise.

Authors:  Randall C Thompson; Harshal Patil; Elaine C Thompson; Gregory S Thomas; Mohammed Al-Amoodi; Kevin F Kennedy; Kevin A Bybee; A Iain McGhie; James H O'Keefe; Lisa Oakes; Timothy M Bateman
Journal:  J Nucl Cardiol       Date:  2012-12-12       Impact factor: 5.952

5.  Advanced hybrid stress testing: a potential new paradigm combining exercise and pharmacologic stress.

Authors:  Gregory S Thomas; Harkawal S Hundal; Myrvin H Ellestad
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

6.  Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: initial clinical experience in 1263 patients.

Authors:  Deborah H Kwon; Manuel D Cerqueira; Ron Young; Penny Houghtaling; Elizabeth Lieber; Venu Menon; Richard C Brunken; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2010-04-23       Impact factor: 5.952

Review 7.  Regadenoson: a focused update.

Authors:  Gopal Ghimire; Fadi G Hage; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2013-04       Impact factor: 5.952

8.  Safety and tolerability of regadenoson in 514 SPECT MPI patients with and without coronary artery disease and submaximal exercise heart rate response.

Authors:  Wael A AlJaroudi; M C Alraies; Manuel D Cerquiera; Wael A Jaber
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-04       Impact factor: 9.236

9.  Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test.

Authors:  Sara L Partington; Viswanatha Lanka; Jon Hainer; Ron Blankstein; Hicham Skali; Daniel E Forman; Marcelo F Di Carli; Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2012-05-08       Impact factor: 5.952

10.  The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol.

Authors:  Gregory S Thomas; S James Cullom; Therese M Kitt; Kathleen M Feaheny; Karthikeyan Ananthasubramaniam; Robert J Gropler; Diwakar Jain; Randall C Thompson
Journal:  J Nucl Cardiol       Date:  2017-02-21       Impact factor: 5.952
View more
  3 in total

1.  A useful and easy to develop combined stress test for myocardial perfusion imaging: Regadenoson and isometric exercise, preliminary results.

Authors:  Lucile Janvier; J Pinaquy; H Douard; G Karcher; L Bordenave
Journal:  J Nucl Cardiol       Date:  2015-11-05       Impact factor: 5.952

2.  The impact of combination of regadenoson and isometric exercise on image quality of myocardial perfusion scintigraphy.

Authors:  Quentin Ceyrat; Charles Mesguich; Lucile Janvier; Hervé Douard; Laurence Bordenave; Jean-Baptiste Pinaquy
Journal:  J Nucl Cardiol       Date:  2016-11-01       Impact factor: 5.952

3.  Is regadenoson an appropriate stressor for MPI in patients with left bundle branch block or pacemakers?

Authors:  Gregory S Thomas; Carissa R Kinser; Rita Kristy; Jiaqiong Xu; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2013-10-17       Impact factor: 5.952
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.